ISBN 10: 0735576637 / ISBN 13: 9780735576636
Gebraucht / Anzahl: 0
Bei weiteren Verkäufern erhältlich
Alle  Exemplare dieses Buches anzeigen

Über dieses Buch

Leider ist dieses Exemplar nicht mehr verfügbar. Wir haben Ihnen weitere Exemplare dieses Titels unten aufgelistet.

Beschreibung:

This Book is in Good Condition. Clean Copy With Light Amount of Wear. 100% Guaranteed. Summary: Completely updated, the new Seventh Edition of Generic and Innovator Drugs: A Guide to FDA Approval Requirements provides indispensable and practical insights into the FDA approval process. You'll find comprehensive coverage of: Abbreviated new drug. Buchnummer des Verkäufers

Über diesen Titel:

Bewertung (bereitgestellt von GoodReads):
0 durchschnittlich
(0 Bewertungen)

Inhaltsangabe:

Completely updated, the new Seventh Edition of Generic and Innovator Drugs: A Guide to FDA Approval Requirements provides indispensable and practical insights into the FDA approval process.

You?ll find comprehensive coverage of:

  • Abbreviated new drug applications
  • 505(b)(2) new drug applications
  • Delaying approval of competing products
  • FDA approval of biologic drugs

No other book can cover the drug approval process as thoroughly, answering important questions like these:

  • What is required to extend the patent of an FDA-approved product?
  • When must a generic manufacturer notify the innovator manufacturer when submitting an ANDA or 505(b)(2) application?
  • When does the FDA delay approvals because of patent claims, and when does it ignore patents?
  • How can one challenge an FDA exclusivity decision?
  • When can a manufacturer safely sell a drug without prior FDA approval?
  • In what circumstances can a generic manufacturer obtain FDA permission to file an ANDA for a variant of an existing drug?
  • When will the FDA waive or reduce prescription drug user fees?
  • How can a company or an individual avoid debarment?
  • What steps are necessary to comply with the FDA?s Fraud Policy?
  • When and how can a drug company take advantage of FDA accelerated approval procedures?
  • What are the labeling requirements for exporting approved drugs?
  • How does the FDAAA of 2007 affect the drug and biologic approval requirements?

Generic and Innovator Drugs: A Guide to FDA Approval Requirements provides step by step guidance of the approval process and expert interpretation of:

  • The Hatch-Waxman Act (Drug Price Competition and Patent Restoration Act)
  • The Medicare Prescription Drug, Improvement, and Modernization Act
  • The Food and Drug Administration Modernization Act
  • The FDA Export Reform and Enhancement Act
  • The Food and Drug Administration Amendments Act of 2007
  • And more!

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Bibliografische Details

Titel: $listing_disp.getBaseListing().getTitle()



Zustand: Used

Beste Suchergebnisse bei AbeBooks

1.

Beers, Donald O.
Verlag: Aspen Publishers (2008)
ISBN 10: 0735576637 ISBN 13: 9780735576636
Gebraucht Anzahl: 2
Anbieter
Books Express
(Portsmouth, NH, USA)
Bewertung
[?]

Buchbeschreibung Aspen Publishers, 2008. Loose Leaf. Buchzustand: Used: Good. We ship International with Tracking Number! May not contain Access Codes or Supplements. Buy with confidence, excellent customer service! j. Buchnummer des Verkäufers 0735576637D

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Gebraucht kaufen
EUR 1.010,34
Währung umrechnen

In den Warenkorb

Versand: EUR 4,68
Innerhalb USA
Versandziele, Kosten & Dauer

2.

Donald O. Beers
Verlag: Aspen Law & Business (2008)
ISBN 10: 0735576637 ISBN 13: 9780735576636
Neu Anzahl: 1
Anbieter
Ergodebooks
(RICHMOND, TX, USA)
Bewertung
[?]

Buchbeschreibung Aspen Law & Business, 2008. Ring-bound. Buchzustand: New. 7 Lslf. Buchnummer des Verkäufers DADAX0735576637

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 1.102,76
Währung umrechnen

In den Warenkorb

Versand: EUR 3,74
Innerhalb USA
Versandziele, Kosten & Dauer